Literature DB >> 7201395

Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.

M M Mareel, G A Storme, G K De Bruyne, R M Van Cauwenberge.   

Abstract

Inhibition of the invasiveness of MO4 mouse fibrosarcoma cells by the vinca alkaloid, vinblastine (VLB), vincristine (VCR) and vindesine (VDS), has been examined in vitro. At doses between 0.006 microgram/ml (minimal effect) and 0.1 microgram/ml (complete inhibition) these drugs interfered with the invasion of MO4 cells from an aggregate confronting a fragment of embryonic chick heart in three-dimensional culture. We have also examined the effect of these drugs on the following activities of MO4 cells: growth, directional migration and assembly of the cytoplasmic microtubule complex. Growth and directional migration were affected by the same doses of vinca alkaloids as invasion. In contrast with the vinca alkaloids, 5-fluorouracil at 1 microgram/ml inhibited growth but allowed directional migration and invasion. At a dose of 0.3 microgram/ml VLB, VCR and VDS interfered with the assembly of cytoplasmic microtubules, as visible after immunocytochemical staining with tubulin antiserum. Ultrastructural analysis demonstrated that inhibition of invasion in three-dimensional culture corresponds with abolishment of the cytoplasmic microtubule complex. Anti-invasive concentrations of VLB, VCR and VDS represent clinically achievable plasma concentrations. We concluded that the anti-invasive effect of the vinca alkaloids may contribute to their antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201395     DOI: 10.1016/0277-5379(82)90064-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  12 in total

1.  Is adjuvant treatment with vinblastine effective in reducing the occurrence of distant metastasis in limited squamous cell lung cancer? A randomized study.

Authors:  D C Schallier; W J De Neve; J L De Greve; S P Van Belle; G J De Wasch; G Dotremont; G A Storme
Journal:  Clin Exp Metastasis       Date:  1988 Jan-Feb       Impact factor: 5.150

2.  The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.

Authors:  E Prange; W Schroyens; H Pralle
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

3.  An image analysis system for the quantification of invasion in vitro.

Authors:  W J de Neve; G A Storme; G K de Bruyne; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

Review 4.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 5.  Temperature-dependent metastasis of the Lucke renal carcinoma and its significance for studies on mechanisms of metastasis.

Authors:  R G McKinnell; D Tarin
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Invasiveness and tumorigenicity of MO4 mouse fibrosarcoma cells pretreated with microtubule inhibitors.

Authors:  C Meyvisch; G A Storme; E Bruyneel; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1983 Jan-Mar       Impact factor: 5.150

7.  Quantitative analysis of cancer invasion in vitro: comparison of two new assays and of tumour sublines with different metastatic capacity.

Authors:  C A Waller; M Braun; V Schirrmacher
Journal:  Clin Exp Metastasis       Date:  1986 Apr-Jun       Impact factor: 5.150

8.  Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.

Authors:  Walter Rhomberg; Helmut Eiter; Franz Schmid; Christoph H Saely
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

9.  Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.

Authors:  Masato Eitaki; Tohru Yamamori; Shunsuke Meike; Hironobu Yasui; Osamu Inanami
Journal:  BMC Cancer       Date:  2012-10-12       Impact factor: 4.430

10.  The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Authors:  Walter Rhomberg
Journal:  Sarcoma       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.